Earlier this month the MIT News published an article titled, “The rise and fall of cognitive skills.”  It discussed research that found different types of thinking skills peak at different times in life.  I particularly like this part: … crystallized intelligence — the accumulation of facts and knowledge … showed a later peak, in the late […]

This article was first published on my CURE Today blog on 11-Mar-2015. ——————————————-  When the Twitter icon indicated I had a new direct message last Tuesday, I took my time opening it. I was down with a bad case of the flu, including a fever and a cough that had stolen my voice, and I […]

Despite the phantom scan snafu (flew to Denver without my scans being scheduled) and a crazy busy schedule, this clinical trial trip to Denver has been great. I avoided the worst of the snowstorm, learned my new North Face Thermoball jacket keeps me toasty in subzero windchill, met my new great nephew Tate AND lung […]

My bimonthly clinical trial appointment is this coming week. I typically fly from Seattle to Denver on Sunday, have my labs and scan on Monday, see my doctor Tuesday, and fly home Wednesday. Scanxiety has a new twist for me this time around. I discovered late Friday that Monday’s scan doesn’t exist in the University […]

On February 19, 2015, I was an invited patient advocate speaker at the 11th Annual Moores Cancer Center Industry/Academia Translational Oncology Symposium. My topic, “EPatients on the Front Lines:  Precision Medicine, the FDA, and Me,” explained how cancer research could move faster and be more successful if researchers, pharmaceutical companies, and the biotech industry would […]

This article first appeared on my February 1, 2015, blog for Cure Today Magazine.  Reprinted here with permission. —————————————- As posted in a recent CURE article, the US Food and Drug Administration (FDA) has proposed draft regulations titled “Framework for Regulatory Oversight of Laboratory Developed Tests (LDTs).”  The FDA should withdraw this proposed framework because […]

The US Food and Drug Administration (FDA) announced its intention to regulate laboratory developed tests.  Under the FDA’s proposed Framework for Regulatory Oversight of Laboratory Developed Tests (LDTs) — which treats LDTs as medical devices and healthcare providers as manufacturers — laboratories would have to submit applications for expensive premarket review for thousands of LDTs […]


Get every new post delivered to your Inbox.

Join 2,421 other followers